VeriMomБезопасен ли lavandula angustifolia flower oil при беременности?
No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
Безопасные альтернативы lavandula angustifolia flower oil при беременности | VeriMom
Related ingredients
Frequently asked questions
- Безопасен ли lavandula angustifolia flower oil при беременности?
- No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
- Безопасен ли lavandula angustifolia flower oil при грудном вскармливании?
- Same rationale as pregnancy: no harmonised classification or regulatory ban; mechanistic/in vitro signals exist but in vivo data do not confirm estrogenicity. Systemic absorption from topical use is low, so maternal exposure and transfer into breastmilk are possible but expected to be low from normal cosmetic use; therefore h=1, m=2, e=1.
- Безопасен ли lavandula angustifolia flower oil для кожи малыша?
- Hazard remains low/theoretical (h=1) because human case reports/in vitro activity exist but no harmonised classification or conclusive animal reproductive/teratogenic evidence. Mechanistic signals (estrogenic/anti‑androgenic activity in vitro) are documented (m=2). Exposure score is increased by +1 for infants (immature skin barrier, higher surface-to-weight ratio) giving e=2 for baby topical exposure. Additionally, lavender oil constituents (oxidized linalool) are recognised contact allergens—relevance for infant skin sensitization is separate from reproductive scoring.
- Как VeriMom оценивает lavandula angustifolia flower oil?
- VeriMom оценивает lavandula angustifolia flower oil в 60/100 (средний риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы lavandula angustifolia flower oil при беременности?
- См. наш список безопасных альтернатив lavandula angustifolia flower oil с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.